What we're reading, November 10, 2016: right-to-die supporters start eyeing the next states; healthcare winners and losers after the election; and women are promoting birth control access before the Affordable Care Act is dismantled.
On Election Day, Colorado approved an initiative that would provide access to life-ending medications for terminally ill patients. According to Kaiser Health News, supporters of the initiative are now turning their gaze on other parts of the country. The District of Columbia may be the next to approve such legislation, there is pending legislation in New Jersey, and New York may reintroduce a right-to-die law in January. Supporters are also prepared to campaign in Maryland, Minnesota, Hawaii, New Mexico, and Massachusetts.
There is a lot of uncertainty in the healthcare industry following Donald Trump’s election. Drug makers’ stocks were up, but hospital stocks were down the day after Election Day, and the Affordable Care Act (ACA) seems poised to be gutted. The Washington Post outlined the winners and losers in the aftermath of the election and highlighted the confusion among companies as they try to understand what a repeal of President Barack Obama’s healthcare law will actually mean for business.
Women are taking to social media to encourage each other to get to the gynecologist and enjoy access to contraceptives as guaranteed under Obamacare while they still can. Women are concerned that birth control costs will increase and access to Planned Parenthood limited under the next administration, reported USA TODAY. In particular, the intrauterine device is being promoted because it can last between 3 and 12 years, is heavily subsidized or free under the ACA, and once it is implanted the only additional costs or maintenance come if there are complications or the device is removed.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More